Company intelligence / Profile preview

CREM

Ontario, Canada

Ownership: Private
Development stage: Other

Overview

CREM functions as a GLP-compliant contract and R&D laboratory focused on infection prevention and control, environmental microbiology, antimicrobial efficacy, toxicology testing, antimicrobial drug screening, antibiotic resistance characterization, and drug screening using zebrafish. There are no clinical-stage or human therapeutic programs; the company supports drug discovery and development through laboratory services.

Industry: Drug Discovery Services

Partnerships

Serves as a partner for various undisclosed industry leaders

Beyond the preview

Go deeper on CREM.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CREM.

Explore the full profile